CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $3.13B, above the global median of $1.15B
- PositionP/E ratio is 8.91×, lower than 95% of its Medical Instruments & Supplies peers (median 30.34×)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
2.71BEUR3.13B · vs all stocks (USD)
Trailing P/E
8.91xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.08BEUR2.40B · vs all stocks (USD)
Profit Margin
14.81%vs Medical Instruments & Supplies peers
Beta
0.8980xvs all stocks
52-Week Change
-44.84%vs all stocks
Market Capitalization
2.71BEUR3.13B · vs all stocks (USD)
Enterprise Value
6.99BEUR8.07B · vs all stocks (USD)
Trailing P/E
8.91xvs Medical Instruments & Supplies peers
PEG Ratio
-0.0668xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.40xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.40xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.36xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
17.87xvs Medical Instruments & Supplies peers
Gross Margin
48.63%vs Medical Instruments & Supplies peers
Profit Margin
14.81%vs Medical Instruments & Supplies peers
Operating Margin
17.74%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
4.16%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.64%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.08BEUR2.40B · vs all stocks (USD)
Revenue per Share (TTM)
23.20EURUpdated Jul 14, 2026Quarterly Revenue Growth
12.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.21BEUR1.39B · vs all stocks (USD)
EBITDA (TTM)
195.56MEUR225.73M · vs all stocks (USD)
Net Income (TTM)
307.91MEUR355.42M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
47.40%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
79.42MEUR91.67M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
141.21MEUR163.00M · vs all stocks (USD)
Payout Ratio
31.98%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
11.19MEURFY2025 · Sep 30, 2025Revenue
2.23BEURFY2025 · Sep 30, 2025Cost of Goods Sold
1.05BEURFY2025 · Sep 30, 2025Gross Profit
1.18BEURFY2025 · Sep 30, 2025Operating Income
223.32MEUR257.78M · vs all stocks (USD)
Pre-tax Income
193.89MEURFY2025 · Sep 30, 2025Income Tax Expense
51.55MEURFY2025 · Sep 30, 2025Net Income
142.34MEURFY2025 · Sep 30, 2025EBIT
220.52MEURFY2025 · Sep 30, 2025EBITDA (Income Statement)
331.79MEURFY2025 · Sep 30, 2025Research & Development
326.27MEURFY2025 · Sep 30, 2025Selling, General & Administrative
626.52MEURFY2025 · Sep 30, 2025Non-operating Interest Income
6.57MEURFY2025 · Sep 30, 2025Non-operating Interest Expense
26.62MEURFY2025 · Sep 30, 2025Net Income from Continuing Operations
142.34MEURFY2025 · Sep 30, 2025Minority Interests (P&L)
-1.14MEURFY2025 · Sep 30, 2025Preferred Stock Dividends
0.00EURFY2025 · Sep 30, 2025Operating Cash Flow
79.42MEURFY2025 · Sep 30, 2025Free Cash Flow
40.03MEURFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
27.27MEURFY2025 · Sep 30, 2025Starting Profit (CF Statement)
142.34MEURFY2025 · Sep 30, 2025Other Non-cash Items
17.21MEURFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
-106.48MEURFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
26.34MEURFY2025 · Sep 30, 2025Capital Expenditures
-39.39MEURFY2025 · Sep 30, 2025Net Intangibles (CF)
-23.51MEURFY2025 · Sep 30, 2025Net Acquisitions
-2.47MEURFY2025 · Sep 30, 2025Purchase of Investments
-25.65MEURFY2025 · Sep 30, 2025Net Investing Cash Flow
-67.52MEURFY2025 · Sep 30, 2025Long-term Debt Issuance
0.00EURFY2025 · Sep 30, 2025Net Short-term Debt Issuance
68.00KEURFY2025 · Sep 30, 2025Common Stock Repurchase
0.00EURFY2025 · Sep 30, 2025Common Dividends Paid
-52.52MEURFY2025 · Sep 30, 2025Other Financing Charges
-29.32MEURFY2025 · Sep 30, 2025Net Financing Cash Flow
-81.78MEURFY2025 · Sep 30, 2025Shares Outstanding
89.44MSharesUpdated Jul 14, 2026Float Shares
36.45MSharesUpdated Jul 14, 2026% Held by Insiders
59.14%vs all stocks
% Held by Institutions
20.16%vs all stocks
Total Cash (MRQ)
12.36MEUR14.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1380EURUpdated Jul 14, 2026Total Debt (MRQ)
156.75MEUR180.93M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0792xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.34xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
21.84EURUpdated Jul 14, 2026Total Assets
3.40BEUR3.92B · vs all stocks (USD)
Total Current Assets
1.27BEURFY2025 · Sep 30, 2025Total Liabilities
1.28BEURFY2025 · Sep 30, 2025Total Non-current Assets
2.12BEURFY2025 · Sep 30, 2025Total Non-current Liabilities
731.86MEURFY2025 · Sep 30, 2025Total Current Liabilities
543.81MEURFY2025 · Sep 30, 2025Cash
27.27MEURFY2025 · Sep 30, 2025Cash & Cash Equivalents
27.27MEURFY2025 · Sep 30, 2025Accounts Receivable
209.01MEURFY2025 · Sep 30, 2025Inventory
496.98MEURFY2025 · Sep 30, 2025Accounts Payable
194.10MEURFY2025 · Sep 30, 2025Short-term Debt
24.14MEURFY2025 · Sep 30, 2025Other Current Liabilities
11.64MEURFY2025 · Sep 30, 2025Long-term Debt
108.32MEURFY2025 · Sep 30, 2025Other Non-current Liabilities
16.32MEURFY2025 · Sep 30, 2025Common Stock (Book)
89.44MEURFY2025 · Sep 30, 2025Retained Earnings
1.58BEURFY2025 · Sep 30, 2025Total Shareholders' Equity
2.13BEUR2.46B · vs all stocks (USD)
Treasury Stock
150.07MEURFY2025 · Sep 30, 202552-Week Low
22.70EURUpdated Jul 14, 202652-Week High
52.85EURUpdated Jul 14, 202652-Week Change
-44.84%vs all stocks
Beta
0.8980xvs all stocks
50-Day MA
26.49EURUpdated Jul 14, 2026200-Day MA
32.65EURUpdated Jul 14, 2026Avg 10-Day Volume
21.81KSharesUpdated Jul 14, 2026Avg 30-Day Volume
16.91KSharesUpdated Jul 14, 2026Diluted EPS (TTM)
3.42EURUpdated Jul 14, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 8.91×, lower than 95% of its Medical Instruments & Supplies peers (median 30.34×)Notable
P/E ratio: 8.91Industry median: 30.34Industry P5: 14.42Peers compared: 65.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 355,416,270.376Operating Cash Flow (USD, TTM): 91,673,711.8
Financial Health
Altman Z-Score 3.05: safe zoneNotable
Altman Z-Score: 3.05
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $3.13B, above the global median of $1.15BNotable
Market cap (USD): 3,131,540,128.219Global Median: 1,146,734,693.424
Revenue is $2.4B, above the global median of $520.53MNotable
Revenue (USD): 2,400,387,609.44Global Median: 520,528,949.311
Levered free cash flow is $163M, above the global median of $16.24MNotable
Levered free cash flow (USD): 162,997,290.9Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Gentech Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Wingtech Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jiangsu Shemar Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Sichuan Hebang Biotechnology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Titan America S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Zesum Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ashland Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Grail, Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Hayward Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Create Century Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Boise Cascade Company
1 interpretationIndustry-Benchmarked Return on Capital Elevated
MiMedx Group, Inc.
1 interpretationIndustry-Benchmarked Return on Capital Elevated
Deepak Nitrite Ltd.
1 interpretationIndustry-Benchmarked Return on Capital Elevated